Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Amarin Corporation plc - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
AMRN
Nasdaq
2836
www.amarincorp.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Amarin Corporation plc
Amarin Corp PLC (AMRN) Q2 2026 Earnings Call Highlights: Strategic Growth Amidst Revenue Challenges
- Jul 29th, 2026 1:03 pm
Amarin's Q2 Earnings Beat Estimates, Revenues Fall Short
- Jul 29th, 2026 10:17 am
European Equities Traded in US as ADRs Ease in Wednesday Trading
- Jul 29th, 2026 9:05 am
Amarin Reports Second-Quarter Results as Partnered International Strategy Gains Momentum
- Jul 29th, 2026 8:42 am
Amarin Q2 Earnings Call Highlights
- Jul 29th, 2026 7:03 am
Amarin Reports 2026 Second Quarter Financial Results Demonstrating Early Success of Fully Partnered International Commercial Strategy and Continued Leading U.S. Market Presence
- Jul 29th, 2026 5:00 am
AGIO Shares Sink Nearly 7% After Scrapping the Tebapivat SCD Program
- Jul 22nd, 2026 10:22 am
Here's Why You Should Add Savara Stock to Your Portfolio Now
- Jul 22nd, 2026 7:21 am
Acadia Gets FDA's Fast Track Tag for Alzheimer's Disease Candidate
- Jul 21st, 2026 8:47 am
DYN Stock Rises 19.2% in 3 Months: What's Driving the Rally?
- Jul 21st, 2026 8:20 am
ZNTL Stock Rises 28% in 3 Months: What's Driving the Rally?
- Jul 20th, 2026 7:26 am
Here's Why You Should Add INKT Stock to Your Portfolio Now
- Jul 16th, 2026 10:24 am
Are Medical Stocks Lagging Acumen Pharmaceuticals (ABOS) This Year?
- Jul 15th, 2026 7:40 am
Summit to Divest Late-Stage Antibiotic Drug to Biossil in $105M Deal
- Jul 15th, 2026 6:48 am
Amarin to Report Second Quarter 2026 Financial Results and Host Conference Call on July 29, 2026
- Jul 15th, 2026 6:00 am
CG Oncology Stock Gains 12% in Three Months: What's Driving It?
- Jul 13th, 2026 7:03 am
Immunome Stock Up 32% in a Month: Here's What You Should Know
- Jul 10th, 2026 8:40 am
FBRX Stock Rallies 78% on Positive Early-Stage Vitiligo Study Data
- Jul 10th, 2026 8:18 am
Bears are Losing Control Over Amarin (AMRN), Here's Why It's a 'Buy' Now
- Jul 10th, 2026 7:55 am
United Therapeutics Stock Rises 14% YTD: Here's What You Need to Know
- Jul 9th, 2026 12:26 pm
Scroll